Trazodone Withdrawal: Rebound Insomnia and How to Taper
Clinically reviewed by Daniel Montville, MD
Reviewed October 21, 2026 · Last updated September 30, 2026
Key Takeaways
- Trazodone isn't a controlled substance, but stopping it can cause withdrawal symptoms such as anxiety, agitation, and trouble sleeping. Its label advises lowering the dose gradually whenever possible.
- Rebound insomnia is sleep that's worse than it was before treatment, soon after a dose cut. It's different from your original insomnia returning, which needs its own plan.
- There's little research on tapering trazodone at sleep doses, so the step-down should be individualized: smaller cuts, a pause at each step, and a pace you agree on with your prescriber.
- Cognitive behavioral therapy for insomnia (CBT-I) is strongly recommended for chronic insomnia and may make coming off a sleep medication easier.
You started trazodone to get some sleep, and it helped. Now you’d like to stop, maybe because mornings feel foggy, or because you never planned to take it forever. Then you skip one night, lie awake until 3 a.m., and wonder whether you’ll ever sleep without it. That fear is common, and it deserves a real answer.
Your sleep system adapts to what it gets every night. At the low doses used for sleep, trazodone mainly blocks serotonin 5-HT2A, histamine H1, and alpha-1 adrenergic receptors, according to a pharmacology review, and that blockade is what makes it sedating. Your brain can adjust to that nightly nudge, so removing it may leave a gap before your own rhythm fills in. Stepping down well takes precision about what’s actually causing a bad night.
The standard advice is simple and sound. Trazodone’s FDA prescribing information says to reduce the dose gradually rather than stopping abruptly whenever possible, and a 2023 sleep guideline from the Alliance for Sleep recommends the same for antidepressants used off-label for insomnia. The label also notes that trazodone isn’t a controlled substance. That guidance is well founded, and it’s the right place to start.
But researchers haven’t studied how dose affects withdrawal or rebound insomnia when trazodone is used for sleep, and at Siggy we’d rather pace a step-down to how you’re actually sleeping than to a fixed calendar. This guide covers what withdrawal can feel like, how to tell rebound insomnia from the sleep problem you started with, and what a slow, symptom-guided taper looks like. Each calls for a different next step.
What This Page Covers
- The Short Answer
- Is Trazodone Withdrawal Real?
- Why Does Stopping Trazodone Disrupt Sleep?
- Rebound Insomnia or the Insomnia You Started With?
- What a Slow Step-Down Looks Like
- How to Protect Your Sleep During a Taper
- When to Get Help Right Away
The Short Answer
Trazodone is FDA approved for depression in adults, and using it for sleep is off-label. Stopping it can cause withdrawal symptoms, including anxiety, agitation, and sleep problems, so its label advises lowering the dose gradually. A slow, step-by-step reduction planned with your prescriber, paired with non-drug insomnia treatment, is the most careful approach.
Some bad nights after a cut are rebound insomnia, which is often short-lived. If your sleep settles back to how it was before trazodone and stays there, that’s your original insomnia, and it needs its own plan.
Is Trazodone Withdrawal Real?
Yes, it can happen. The FDA label warns that adverse reactions can follow stopping serotonergic antidepressants, particularly abruptly, including nausea, sweating, irritability, dizziness, electric shock sensations, anxiety, headache, and insomnia. Trazodone’s Medication Guide tells patients withdrawal can include anxiety, agitation, and sleep problems.
Most of what’s known about trazodone specifically comes from case reports. The Alliance for Sleep guideline describes a man who stopped 300 mg abruptly and within 36 hours had restless sleep, nightmares, and intense anxiety that resolved within five days. A 1994 case series described three people who developed withdrawal symptoms even after a gradual taper, and its authors advised tapering trazodone at a very slow rate. Those cases involved doses of 150 to 300 mg, and data at 25 to 100 mg are scarce.
How long it lasts varies. The UK’s NICE guidance notes that antidepressant withdrawal symptoms usually ease within one to two weeks, though some people have them longer.
Withdrawal isn’t the same as addiction, and the label reports no sign of drug-seeking behavior in trazodone’s clinical studies. If you’ve come off an SSRI before, our guide to brain zaps covers antidepressant discontinuation in more depth.
Why Does Stopping Trazodone Disrupt Sleep?
Two different things can happen when the drug comes out.
The first is adjustment. Trazodone and its active metabolite, m-CPP, act on serotonin systems. The authors of the 1994 case series proposed that stopping may trigger a rebound in noradrenaline, a chemical involved in alertness, made worse by the short half-lives of both compounds. That’s a hypothesis from case reports, not a settled mechanism.
The second is the original problem returning. The Alliance for Sleep guideline expects baseline insomnia symptoms to come back in many cases after a sleep medication stops. It notes that CBT-I’s benefits tend to last after treatment ends, while lasting improvement after stopping a sleep medication is less predictable.
Small trazodone studies point the same way. In one six-person study, sleep changes on controlled-release trazodone returned to pre-treatment levels after it stopped. In a study of 29 people with insomnia, only those with higher depression scores had significantly worse sleep after coming off, which suggests underlying mood symptoms can shape how stopping goes.
Rebound Insomnia or the Insomnia You Started With?
Rebound insomnia means sleep that’s worse than your pre-treatment baseline soon after a sleep medication stops. In the Alliance for Sleep review, rebound after zolpidem usually lasted one night.
A rough night isn’t always the drug, either. In a 12-month zolpidem study, about 30 to 40% of participants met criteria for rebound insomnia when switched to placebo, and so did a similar share of people who’d been on placebo all along. It wasn’t a trazodone study, but it suggests one bad night after a cut isn’t proof you need the pill.
This comparison draws on the Alliance for Sleep guideline, the trazodone label, and a 2019 tapering review:
| Pattern | What It Looks Like | What It Usually Means |
|---|---|---|
| Rebound insomnia | Sleep worse than before you started, soon after a cut | A temporary adjustment, often short-lived |
| Withdrawal symptoms | New anxiety, agitation, dizziness, or nausea within days of a cut | Your body reacting to the change, a reason to slow down |
| Return of original insomnia | Sleep settles back to your old pattern and stays there | The underlying sleep problem needs its own treatment |
The tapering review lists clues that point to withdrawal rather than relapse: symptoms that start within days of a change rather than weeks, physical sensations like dizziness that weren’t part of the original problem, and quick relief when the previous dose is restarted. Those clues come from SSRI research, though the review notes every antidepressant class can cause withdrawal.
A simple sleep diary helps, and CBT-I uses one too. Each morning, note bedtime, wake time, rough hours slept, and any new symptoms, ideally starting before your first cut.
What a Slow Step-Down Looks Like
People step down for different reasons, such as next-day drowsiness, dizziness when standing, or learning that a 2017 AASM guideline suggests clinicians not use trazodone for insomnia. That’s a weak recommendation, reflecting lower certainty in the evidence.
No trial has defined the ideal trazodone taper for sleep. The Alliance for Sleep guideline recommends individualized reductions based on dose, how the drug acts, and whether another sleep treatment is being added, and it calls it an open question whether any dose is low enough to skip tapering. Expect your prescriber to ask about your dose, how long you’ve taken it, and whether anxiety or low mood is part of the picture.
The closest general framework comes from NICE antidepressant guidance, which recommends:
- Reducing the dose in steps, each a proportion of the previous dose, such as 50%.
- Using smaller cuts, such as 25%, as the dose gets lower.
- Tapering short half-life medications more slowly.
- Waiting until withdrawal symptoms have resolved or become tolerable before the next cut.
- Letting the pace be led by and agreed with the person taking the medication.
Here’s how that can translate for someone on 50 mg a night, as an illustration rather than a schedule to follow on your own. Trazodone tablets are scored, and the label allows breaking them in half along the score line, so a first step from 50 mg to 25 mg is often possible with tablets you already have. Your prescriber might keep you at 25 mg until your sleep settles, then decide with you whether to stop there or add a smaller final step. NICE notes that liquid forms can allow smaller cuts when tablets can’t.
If a step brings rough nights or new symptoms that don’t ease, your prescriber may suggest returning to your last comfortable dose, since restarting usually relieves withdrawal quickly, and then stepping down more slowly.
How to Protect Your Sleep During a Taper
- Ask about CBT-I. AASM insomnia therapy guidance strongly recommends multicomponent cognitive behavioral therapy for insomnia in adults with chronic insomnia. It combines techniques like stimulus control and sleep restriction, and the Alliance for Sleep guideline notes it may help people transition off sleep medication.
- Keep your wake time steady, even after a rough night. A consistent wake time is part of stimulus control, a core piece of CBT-I.
- Time your cuts for a stretch without big deadlines or travel.
- Check before adding anything. The label warns that trazodone can enhance the effects of alcohol and other sedatives, which still matters while you’re tapering.
- Know what to expect. The guideline notes that deprescribing tends to go better when people understand what may happen and help make the decision.
When to Get Help Right Away
Most withdrawal symptoms aren’t emergencies, but some need prompt care:
- If you have thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline.
- If you have a seizure, faint, or feel you’re in immediate danger, call 911.
- Call your prescriber promptly if you notice new or worse depression or anxiety, panic attacks, severe agitation, or an unusual burst of energy and talkativeness. The Medication Guide flags these changes, and the label advises close monitoring whenever a dose changes.
For a lot of people, trazodone was a fix for sleep that was tangled up with anxiety or low mood all along.
Coming off trazodone works best as a planned, gradual process: small steps, a pause at each one, and a clear way to tell rebound from your original insomnia. If you’re still weighing whether trazodone fits your sleep at all, our guide to low-dose trazodone for sleep covers how it works and who it suits.
Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.
This article is for education only and isn’t a substitute for personal medical advice. Don’t change or stop a medication without talking to your prescriber. It was reviewed for clinical accuracy and reflects sources available as of September 2026.
Mental healthcare should stay with you between appointments.
Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.
Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.
Frequently Asked Questions
Is trazodone withdrawal real?
Yes, it can happen. Trazodone's FDA label says adverse reactions may occur when it's stopped and recommends lowering the dose gradually rather than stopping abruptly whenever possible. Reported symptoms include anxiety, agitation, dizziness, nausea, and sleep problems. Research at low sleep doses is limited, so a gradual taper planned with your prescriber is the safer default.
How long does trazodone withdrawal last?
It varies, and trazodone-specific data are limited. NICE notes that antidepressant withdrawal symptoms usually ease within one to two weeks, though some people have them longer. In several published case reports, symptoms started within two days of the last dose. Contact your prescriber if symptoms last or feel severe.
What is rebound insomnia?
Rebound insomnia is sleep that becomes worse than it was before treatment, soon after a sleep medication is stopped or cut. With the sleep medications studied most, it's often short-lived. It's different from your original insomnia coming back, which needs its own treatment, such as cognitive behavioral therapy for insomnia (CBT-I).
Do I need to taper 25 or 50 mg of trazodone?
Talk with your prescriber before stopping, even at a low dose. Trazodone's label recommends gradual reduction whenever possible, and a 2023 sleep medicine guideline says off-label antidepressants used for insomnia should be reduced gradually. The same guideline calls it an open question whether any dose is low enough to skip tapering.
What does a slow trazodone taper look like?
A slow taper lowers the dose in steps and pauses at each step until sleep and any withdrawal symptoms settle. NICE antidepressant guidance suggests cutting a proportion of the current dose, such as half, with smaller cuts as the dose gets lower. Your prescriber sets the exact steps based on your dose, history, and response.
Is trazodone addictive?
Trazodone isn't a controlled substance, and its FDA label reports no sign of drug-seeking behavior in clinical studies. Withdrawal symptoms after stopping aren't the same as addiction, but they're a good reason to lower the dose gradually with your prescriber rather than stopping all at once.
Sources
- Stahl SM. Mechanism of action of trazodone: a multifunctional drug. CNS Spectrums. 2009;14(10):536-546. doi:10.1017/s1092852900024020
- Pragma Pharmaceuticals. DESYREL (trazodone hydrochloride) tablets, prescribing information and Medication Guide. U.S. Food and Drug Administration; revised June 2017. accessdata.fda.gov
- Watson NF, Benca RM, Krystal AD, McCall WV, Neubauer DN. Alliance for Sleep clinical practice guideline on switching or deprescribing hypnotic medications for insomnia. Journal of Clinical Medicine. 2023;12(7):2493. doi:10.3390/jcm12072493
- Otani K, Tanaka O, Kaneko S, Ishida M, Yasui N, Fukushima Y. Mechanisms of the development of trazodone withdrawal symptoms. International Clinical Psychopharmacology. 1994;9(2):131-133. doi:10.1097/00004850-199400920-00011
- Roehrs T, Randall S, Harris EJ, Maan R, Roth T. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. Journal of Psychopharmacology. 2012;26(8):1088-1095. doi:10.1177/0269881111424455
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538-546. doi:10.1016/S2215-0366(19)30032-X
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2017;13(2):307-349. doi:10.5664/jcsm.6470
- National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222. 2022. nice.org.uk
- Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. 2021;17(2):255-262. doi:10.5664/jcsm.8986